Interferon alpha-2a biosimilar - EleaAlternative Names: r-hu-IFNa2 - Elea
Latest Information Update: 27 Jul 2015
At a glance
- Originator Elea
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Interferon alfa 2a stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer; Neurological disorders; Viral infections